GNAQ/GNA11 Mosaicism Causes Aberrant Calcium Signaling Susceptible to Targeted TherapeuticsDavide Zecchin, Veronica A. Kinsler|Journal of Investigative Dermatology|2023Cited by 21
<i>BRAF</i> V600E Is a Determinant of Sensitivity to Proteasome InhibitorsDavide Zecchin, Federica Di Nicolantonio|Molecular Cancer Therapeutics|2013Cited by 20
Mosaic BRAF Fusions Are a Recurrent Cause of Congenital Melanocytic Nevi Targetable by MAPK Pathway InhibitionSara Barberan-Martin, Veronica A. Kinsler, Alicia L. Bruzos et al.|Journal of Investigative Dermatology|2023Cited by 20